![Inhibition of type 1 immunity with tofacitinib is associated with marked improvement in longstanding sarcoidosis | Nature Communications Inhibition of type 1 immunity with tofacitinib is associated with marked improvement in longstanding sarcoidosis | Nature Communications](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41467-022-30615-x/MediaObjects/41467_2022_30615_Fig1_HTML.png)
Inhibition of type 1 immunity with tofacitinib is associated with marked improvement in longstanding sarcoidosis | Nature Communications
![How cells sense and integrate information from different sources - Ullo - 2023 - WIREs Mechanisms of Disease - Wiley Online Library How cells sense and integrate information from different sources - Ullo - 2023 - WIREs Mechanisms of Disease - Wiley Online Library](https://wires.onlinelibrary.wiley.com/cms/asset/62a8c565-d12e-4545-83df-8f8c7c040931/wsbm1604-toc-0001-m.jpg)
How cells sense and integrate information from different sources - Ullo - 2023 - WIREs Mechanisms of Disease - Wiley Online Library
![Frontiers | Intraperitoneal metastasis of ovarian cancer: new insights on resident macrophages in the peritoneal cavity Frontiers | Intraperitoneal metastasis of ovarian cancer: new insights on resident macrophages in the peritoneal cavity](https://www.frontiersin.org/files/Articles/1104694/fimmu-14-1104694-HTML/image_m/fimmu-14-1104694-g001.jpg)
Frontiers | Intraperitoneal metastasis of ovarian cancer: new insights on resident macrophages in the peritoneal cavity
![Mechanisms of dermatological toxicities to immune checkpoint inhibitor cancer therapies - Seervai - 2022 - Clinical and Experimental Dermatology - Wiley Online Library Mechanisms of dermatological toxicities to immune checkpoint inhibitor cancer therapies - Seervai - 2022 - Clinical and Experimental Dermatology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/8dae8db7-dbeb-4354-854f-ee1e75bfb678/ced15332-toc-0001-m.jpg?trick=1694092289815)